Touchstone
Last syncOct 31, 2026, 6:54 PM ET

LFST

Lifestance Health Group, Inc. Health Care Services-Health Services Russell 3000
$13.40Close $5.2BMarket cap $4.81 – $13.6452-week range Nov 5, 2026Next report · before the open

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 97 · stronger than 97% of stocks over 12 months
  • RS line at a 1-year high outperforming the S&P 500 more than at any point this year
  • Near its high 2% below its 52-week high

Cautions

  • Past its pivot 5.7% above its $12.68 pivot
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 2%
1wk up 3.6% price change
1mo up 11.4% price change
12-month return up 173% market up 11% · its own up 158%
F-score — — Not assessed
Altman Z″ 1.70 Moderate risk
P/E 538.5× price / earnings
PEG — P/E / EPS growth
P/B 3.4× price / book
Earnings yield up 0.5% EBIT / enterprise value
Cheaper than 37% of the market · expensive
Revenue growth up 14% year on year
EPS growth — latest quarter
Sales growth up 26% latest quarter · +5 pts
ROE up 1% return on equity
Free cash margin up 8% $110.0M FCF
D/E 0.17 long-term debt / equity
Net debt / EBITDA 0.3×
Interest cover 2.1×EBIT / interest

Trade setup

ATR% 3.2% $0.43 a day · 2×ATR $12.55
RS 97 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.5× vs 50-day average
Up/down volume 0.82 50 sessions
Implied move — no option chain · report Nov 5, 2026
Contractions 2 15% → 8%
Pivot $12.68 5.7% above
Volume dry-up 0.8× 10 vs 50 sessions
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 6, 2026
Results reaction Aug 6, 2026+4% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.4B +14% on FY2024
$0 $2B FY19 FY21 FY22 FY23 FY24 FY25 FY2019 · $212.5M FY2021 · $1.4M FY2022 · $859.5M FY2023 · $1.1B FY2024 · $1.3B FY2025 · $1.4B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $9.7M back to a profit
-$500M $0 FY19 FY21 FY22 FY23 FY24 FY25 FY2019 · $5.7M FY2021 · -$307.2M FY2022 · -$215.6M FY2023 · -$186.3M FY2024 · -$57.4M FY2025 · $9.7M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $110.0M +28% on FY2024
-$100M $0 $200M FY19 FY21 FY22 FY23 FY24 FY25 FY2019 · $2.7M FY2021 · -$85.1M FY2022 · -$26.5M FY2023 · -$57.4M FY2024 · $85.7M FY2025 · $110.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 1%
  • Free cash 8%
-25000% 0% FY19 FY21 FY22 FY23 FY24 FY25 FY2019 · Net 3% · Free cash 1% FY2021 · Net -21259% · Free cash -5887% FY2022 · Net -25% · Free cash -3% FY2023 · Net -18% · Free cash -5% FY2024 · Net -5% · Free cash 7% FY2025 · Net 1% · Free cash 8%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $17.3M net debt
  • Cash
  • Long-term debt
$0 $500M FY19 FY21 FY22 FY23 FY24 FY25 FY2019 · Cash $3.5M FY2021 · Cash $148.0M · Long-term debt $157.4M FY2022 · Cash $108.6M · Long-term debt $225.1M FY2023 · Cash $78.8M · Long-term debt $280.3M FY2024 · Cash $154.6M · Long-term debt $279.8M FY2025 · Cash $248.6M · Long-term debt $265.9M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 388.32m +1184.5% since FY2019
388.32m 30.23m FY19 FY21 FY22 FY23 FY24 FY25 FY2019 · 30.23m FY2021 · 374.25m FY2022 · 375.96m FY2023 · 378.73m FY2024 · 382.74m FY2025 · 388.32m
  FY2019Dec 31, 2019 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $212.5M $1.4M $859.5M $1.1B $1.3B $1.4B
Operating income $15.2M -$286.4M -$210.2M -$189.1M -$31.6M $24.1M
Net income $5.7M -$307.2M -$215.6M -$186.3M -$57.4M $9.7M
Net margin 3% -21259% -25% -18% -5% 1%
Earnings per share — -$937.94 -$0.61 -$0.51 -$0.15 $0.02
Free cash flow $2.7M -$85.1M -$26.5M -$57.4M $85.7M $110.0M
Free cash margin 1% -5887% -3% -5% 7% 8%
Cash $3.5M $148.0M $108.6M $78.8M $154.6M $248.6M
Long-term debt — $157.4M $225.1M $280.3M $279.8M $265.9M
Shareholders' equity -$166.4M $1.5B $1.5B $1.4B $1.4B $1.5B
Shares outstanding 30.23m 374.25m 375.96m 378.73m 382.74m 388.32m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 25, 2026 Annual ↗ Dec 31, 2025 56d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 8, 2024 Quarterly ↗ Jun 30, 2024 39d
May 9, 2024 Quarterly ↗ Mar 31, 2024 39d
Feb 28, 2024 Annual ↗ Dec 31, 2023 59d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports

FiledDisclosed
Oct 16, 2026 Director or officer change ↗
Sep 11, 2026 Other events ↗
Aug 6, 2026 Results · Regulation FD · Other events ↗
Jul 7, 2026 Director or officer change ↗
Jun 4, 2026 Shareholder vote ↗
May 12, 2026 Other events ↗
May 7, 2026 Results · Regulation FD ↗
Mar 11, 2026 Director or officer change ↗
Mar 2, 2026 Other events ↗
Feb 25, 2026 Results · Director or officer change · Regulation FD · Other events ↗
Nov 6, 2025 Results · Regulation FD ↗
Aug 22, 2025 Director or officer change ↗